Alveolar–Capillary Barrier Protection In Vitro: Lung Cell Type-Specific Effects and Molecular Mechanisms Induced by 1α, 25-Dihydroxyvitamin D3
Authors:
- Junyu XiongJXJunyu Xiong
- Patrick KalejaPKPatrick Kaleja
- Larissa ÜckertLÜLarissa Ückert
- Niloufar NezaratizadehNNNiloufar Nezaratizadeh
- Stefanie KrantzSKStefanie Krantz
- Martin Friedrich KrauseMKMartin Friedrich Krause
- Stefanie Fitschen-OesternSFStefanie Fitschen-Oestern
- Andreas SeekampASAndreas Seekamp
- Liam CassidyLCLiam Cassidy
- Andreas TholeyATAndreas Tholey
- Sabine FuchsSFSabine Fuchs
Open Access
- 14 April 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (8) , 7298
Abstract
Low serum levels of 1α, 25-dihydroxyvitamin D3 (VD3) are associated with a higher mortality in trauma patients with sepsis or ARDS. However, the molecular mechanisms behind this observation are not yet understood. VD3 is known to stimulate lung maturity, alveolar type II cell differentiation, or pulmonary surfactant synthesis and guides epithelial defense during infection. In this study, we investigated the impact of VD3 on the alveolar–capillary barrier in a co-culture model of alveolar epithelial cells and microvascular endothelial cells respectively in the individual cell types. After stimulation with bacterial LPS (lipopolysaccharide), gene expression of inflammatory cytokines, surfactant proteins, transport proteins, antimicrobial peptide, and doublecortin-like kinase 1 (DCLK1) were analyzed by real-time PCR, while corresponding proteins were evaluated by ELISA, immune-fluorescence, or Western blot. The effect of VD3 on the intracellular protein composition in H441 cells was analyzed by quantitative liquid chromatography-mass spectrometry-based proteomics. VD3 effectively protected the alveolar–capillary barrier against LPS treatment, as indicated by TEER measurement and morphological assessment. VD3 did not inhibit the IL-6 secretion by H441 and OEC but restricted the diffusion of IL-6 to the epithelial compartment. Further, VD3 could significantly suppress the surfactant protein A expression induced in the co-culture system by LPS treatment. VD3 induced high levels of the antimicrobial peptide LL-37, which counteracted effects by LPS and strengthened the barrier. Quantitative proteomics identified VD3-dependent protein abundance changes ranging from constitutional extracellular matrix components and surfactant-associated proteins to immune-regulatory molecules. DCLK1, as a newly described target molecule for VD3, was prominently stimulated by VD3 (10 nM) and seems to influence the alveolar–epithelial cell barrier and regeneration.Keywords
Funding Information
- DFG, German Research Foundation (EXC 22167-390884018)
This publication has 82 references indexed in Scilit:
- The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancerRespiratory Research, 2011
- Vitamin D Enhances Corneal Epithelial Barrier FunctionInvestigative Ophthalmology & Visual Science, 2011
- Cholinergic chemosensory cells in the trachea regulate breathingProceedings of the National Academy of Sciences, 2011
- Loss of aquaporin-4 expression and putative function in non-small cell lung cancerBMC Cancer, 2011
- Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epitheliumJournal of Cell Biology, 2011
- Nuclear vitamin D receptor expression is associated with improved survival in non-small cell lung cancerThe Journal of Steroid Biochemistry and Molecular Biology, 2011
- Vitamin D Effects on Lung Immunity and Respiratory Diseases2011
- Knock-Out Models Reveal New Aquaporin Functions2009
- Aquaporins—new players in cancer biologyJournal of Molecular Medicine, 2008
- Vitamin D signalling pathways in cancer: potential for anticancer therapeuticsNature Reviews Cancer, 2007